Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
Current Pharmaceutical Design|May 16, 2009
Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugsHan-Ting ZhangIdrugs : the Investigational Drugs Journal|March 2, 2010
Phosphodiesterase Targets for Cognitive Dysfunction and Schizophrenia--a New York Academy of Sciences MeetingHan Ting ZhangCurrent Pharmaceutical Design|August 28, 2014
Phosphodiesterase-4 modulation as a potential therapeutic for cognitive loss in pathological and non-pathological aging: possibilities and pitfallsRolf T Hansen, Han-Ting ZhangBrain Research|April 30, 2013
Senescent-induced dysregulation of cAMP/CREB signaling and correlations with cognitive declineRolf T Hansen, Han-Ting ZhangAdvances in Neurobiology|September 29, 2017
The Past, Present, and Future of Phosphodiesterase-4 Modulation for Age-Induced Memory LossRolf T Hansen, Han-Ting ZhangAdvances in Neurobiology|September 29, 2017
Interaction of Cdk5 and cAMP/PKA Signaling in the Mediation of Neuropsychiatric and Neurodegenerative DiseasesYafang Hu, Suyue Pan, Han-Ting ZhangThe Journal of Pharmacology and Experimental Therapeutics|September 5, 2003
Antidepressant-induced increase in high-affinity rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic functionYu Zhao, Han-Ting Zhang, James M O'DonnellHandbook of Experimental Pharmacology|June 23, 2011
Phosphodiesterases in the central nervous system: implications in mood and cognitive disordersYing Xu, Han-Ting Zhang, James M O'DonnellThe Journal of Pharmacology and Experimental Therapeutics|April 22, 2003
Inhibitor binding to type 4 phosphodiesterase (PDE4) assessed using [3H]piclamilast and [3H]rolipramYu Zhao, Han-Ting Zhang, James M O'DonnellSpringerplus|May 4, 2013
Effects of rocuronium and vecuronium on initial rundown of endplate potentials in the isolated phrenic nerve diaphragm preparation of ratsJun Li, Yong-Qin Liu, Han-Ting ZhangPageof 12